These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10681347)

  • 1. Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action.
    Adrian PV; Zhao W; Black TA; Shaw KJ; Hare RS; Klugman KP
    Antimicrob Agents Chemother; 2000 Mar; 44(3):732-8. PubMed ID: 10681347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants.
    Adrian PV; Mendrick C; Loebenberg D; McNicholas P; Shaw KJ; Klugman KP; Hare RS; Black TA
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3101-6. PubMed ID: 11036030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mutations in ribosomal protein L16 on susceptibility and accumulation of evernimicin.
    McNicholas PM; Mann PA; Najarian DJ; Miesel L; Hare RS; Black TA
    Antimicrob Agents Chemother; 2001 Jan; 45(1):79-83. PubMed ID: 11120948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (Avilamycin and evernimicin).
    Aarestrup FM; Jensen LB
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3425-7. PubMed ID: 11083650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in ribosomal protein L16 and in 23S rRNA in Enterococcus strains for which evernimicin MICs differ.
    Zarazaga M; Tenorio C; Del Campo R; Ruiz-Larrea F; Torres C
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3657-9. PubMed ID: 12384386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
    Wolter N; Smith AM; Low DE; Klugman KP
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1092-5. PubMed ID: 17210764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evernimicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.
    Champney WS; Tober CL
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1413-7. PubMed ID: 10817686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial.
    Jones RN; Hare RS; Sabatelli FJ;
    J Antimicrob Chemother; 2001 Jan; 47(1):15-25. PubMed ID: 11152427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of pneumococci to evernimicin: effect of CO2 and different methodologies.
    Hamilton-Miller JM; Shah S; Loebenberg D
    Clin Microbiol Infect; 2001 Jun; 7(6):339-40. PubMed ID: 11442569
    [No Abstract]   [Full Text] [Related]  

  • 11. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.
    Reinert RR; Wild A; Appelbaum P; Lütticken R; Cil MY; Al-Lahham A
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2319-22. PubMed ID: 12821488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA.
    Lupien A; Gingras H; Leprohon P; Ouellette M
    J Antimicrob Chemother; 2015 Nov; 70(11):2973-80. PubMed ID: 26183184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance.
    Mann PA; Xiong L; Mankin AS; Chau AS; Mendrick CA; Najarian DJ; Cramer CA; Loebenberg D; Coates E; Murgolo NJ; Aarestrup FM; Goering RV; Black TA; Hare RS; McNicholas PM
    Mol Microbiol; 2001 Sep; 41(6):1349-56. PubMed ID: 11580839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation frequency in antibiotic-resistant and -susceptible isolates of Streptococcus pneumoniae.
    Henderson-Begg SK; Sheppard CL; George RC; Livermore DM; Hall LM
    Int J Antimicrob Agents; 2010 Apr; 35(4):342-6. PubMed ID: 20149603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of penicillin-binding protein genotypes in penicillin susceptible and resistant Streptococcus pneumoniae isolates].
    Aslan G; Tezcan S; Delialioğlu N; Aydın FE; Kuyucu N; Emekdaş G
    Mikrobiyol Bul; 2012 Apr; 46(2):190-201. PubMed ID: 22639308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan.
    Hsieh YC; Chang LY; Huang YC; Lin HC; Huang LM; Hsueh PR
    Clin Microbiol Infect; 2010 Jul; 16(7):973-8. PubMed ID: 19778298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
    Tait-Kamradt A; Davies T; Cronan M; Jacobs MR; Appelbaum PC; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of an evernimicin derivative, SCH27899, against anaerobic bacteria and Propionibacterium acnes.
    Tanaka K; Kato N; Watanabe K
    J Antimicrob Chemother; 2000 Sep; 46(3):465-9. PubMed ID: 10980176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evolution of rifampicin resistance in Streptococcus pneumoniae.
    Enright M; Zawadski P; Pickerill P; Dowson CG
    Microb Drug Resist; 1998; 4(1):65-70. PubMed ID: 9533728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.